Bacterial Membrane, a Key for Controlling Drug Influx and Efflux

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-10-04

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/9783527659685.CH9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure, Function and Regulation of Outer Membrane Proteins Involved in Drug Transport in Enterobactericeae: the OmpF/C – TolC Case

  2013cited by this paper
• Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

  2012cited by this paper
• Silver nanoparticles: the powerful nanoweapon against multidrug‐resistant bacteria

  2012cited by this paper
• Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery.

  2012cited by this paper
• Antimicrobial activity of carvacrol: current progress and future prospectives.

  2012cited by this paper
• The crisis of no new antibiotics--what is the way forward?

  2012cited by this paper
• Temporal Interplay between Efflux Pumps and Target Mutations in Development of Antibiotic Resistance in Escherichia coli

  2012cited by this paper
• Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics.

  2012cited by this paper
• A Microfluidic Device for Simple and Rapid Evaluation of Multidrug Efflux Pump Inhibitors

  2012cited by this paper
• A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity

  2012cited by this paper
• Activity of Polymyxin B and the Novel Polymyxin Analogue CB-182,804 Against Contemporary Gram-Negative Pathogens in New York City

  2012cited by this paper
• Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus

  2012cited by this paper
• The structural biology of β-barrel membrane proteins: a summary of recent reports.

  2011cited by this paper
• In silico screening for antibiotic escort molecules to overcome efflux

  2011cited by this paper
• Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels

  2011cited by this paper
• The MFS efflux proteins of gram-positive and gram-negative bacteria.

  2011cited by this paper
• Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli.

  2011cited by this paper
• Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria.

  2011cited by this paper
• The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A

  2011cited by this paper
• Battacin (Octapeptin B5), a New Cyclic Lipopeptide Antibiotic from Paenibacillus tianmuensis Active against Multidrug-Resistant Gram-Negative Bacteria

  2011cited by this paper
• Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

  2011cited by this paper
• Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes

  2011cited by this paper
• Altered Antibiotic Transport in OmpC Mutants Isolated from a Series of Clinical Strains of Multi-Drug Resistant E. coli

  2011cited by this paper
• Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe

  2011cited by this paper
• Insights on the permeability of wide protein channels: measurement and interpretation of ion selectivity.

  2011cited by this paper
• Discovering new antimicrobial agents.

  2011cited by this paper
• Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

  2011cited by this paper
• Susceptibility of the Multi-drug Resistant Strain of Enterobacter aerogenes EA289 to the Terpene Alcohols from Cistus ladaniferus Essential Oil

  2011cited by this paper
• Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens

  2011cited by this paper
• An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.

  2011cited by this paper
• Designing antimicrobial peptides: form follows function

  2011cited by this paper
• In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.

  2011cited by this paper
• Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents

  2011cited by this paper
• Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram‐Negative Infections: Insights from the Society of Infectious Diseases Pharmacists

  2011cited by this paper
• An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates.

  2011cited by this paper
• Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae

  2011cited by this paper
• PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients

  2011cited by this paper
• Role of the mar-sox-rob Regulon in Regulating Outer Membrane Porin Expression

  2011cited by this paper
• Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.

  2011cited by this paper
• Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria

  2011cited by this paper
• Identification of Hopanoid Biosynthesis Genes Involved in Polymyxin Resistance in Burkholderia multivorans

  2011cited by this paper
• Insect natural products and processes: new treatments for human disease.

  2011cited by this paper
• Bile Salts Induce Resistance to Polymyxin in Enterohemorrhagic Escherichia coliO157:H7

  2011cited by this paper
• Structure and mechanism of RND-type multidrug efflux pumps.

  2011cited by this paper
• Role of calcium in the efflux system of Escherichia coli.

  2011cited by this paper
• Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains.

  2011cited by this paper
• Efflux pumps of gram-negative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines.

  2011cited by this paper
• Efflux pumps of the resistance-nodulation-division family: a perspective of their structure, function, and regulation in gram-negative bacteria.

  2011cited by this paper
• In Vitro and In Vivo Properties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases

  2011cited by this paper
• Creeping baselines and adaptive resistance to antibiotics.

  2011cited by this paper
• "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.

  2011cited by this paper
• Efflux pumps as an important mechanism for quinolone resistance.

  2011cited by this paper
• Lipopolysaccharide: Biosynthetic pathway and structure modification.

  2010cited by this paper
• Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains.

  2010cited by this paper
• Optimized Nile Red Efflux Assay of AcrAB-TolC Multidrug Efflux System Shows Competition between Substrates

  2010cited by this paper
• The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.

  2010cited by this paper
• Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit

  2010cited by this paper
• In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli

  2010cited by this paper
• A Mycobacterium tuberculosis Sigma Factor Network Responds to Cell-Envelope Damage by the Promising Anti-Mycobacterial Thioridazine

  2010cited by this paper
• Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains.

  2010cited by this paper
• Toward screening for antibiotics with enhanced permeation properties through bacterial porins.

  2010cited by this paper
• The Complexities of Porin Genetic Regulation

  2010cited by this paper
• Expression of Multidrug Efflux Pump Genes acrAB-tolC, mdfA, and norE in Escherichia coli Clinical Isolates as a Function of Fluoroquinolone and Multidrug Resistance

  2010cited by this paper
• Kinetic Parameters of Efflux of Penicillins by the Multidrug Efflux Transporter AcrAB-TolC of Escherichia coli

  2010cited by this paper
• Correlation of Overexpression of Efflux Pump Genes with Antibiotic Resistance in Escherichia coli Strains Clinically Isolated from Urinary Tract Infection Patients

  2010cited by this paper
• Molecular simulations reveal the mechanism and the determinants for ampicillin translocation through OmpF.

  2010cited by this paper
• Polymyxins and their novel derivatives.

  2010cited by this paper
• Non-antibiotics reverse resistance of bacteria to antibiotics.

  2010cited by this paper
• Increasing of the Aminoglicosyde Antibiotic Activity Against a Multidrug-Resistant E. coli by Turnera ulmifolia L. and Chlorpromazine

  2010cited by this paper
• On the mechanisms of phenothiazine-induced mitochondrial permeability transition: Thiol oxidation, strict Ca2+ dependence, and cyt c release.

  2010cited by this paper
• Resistance to polymyxins: Mechanisms, frequency and treatment options.

  2010cited by this paper
• Membrane Efflux and Influx Modulate both Multidrug Resistance and Virulence of Klebsiella pneumoniae in a Caenorhabditis elegans Model

  2010cited by this paper
• Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

  2010cited by this paper
• Structure--activity relationships of polymyxin antibiotics.

  2010cited by this paper
• Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

  2010cited by this paper
• Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City

  2010cited by this paper
• Challenges of antibacterial discovery revisited

  2010cited by this paper
• Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.

  2010cited by this paper
• Induction of Fatty Acid Composition Modifications and Tolerance to Biocides in Salmonella enterica Serovar Typhimurium by Plant-Derived Terpenes

  2010cited by this paper
• Does the Wide Use of Quaternary Ammonium Compounds Enhance the Selection and Spread of Antimicrobial Resistance and Thus Threaten Our Health?

  2010cited by this paper
• Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

  2010cited by this paper
• Antimicrobial natural products: an update on future antibiotic drug candidates.

  2010cited by this paper
• Bridging timescales and length scales: from macroscopic flux to the molecular mechanism of antibiotic diffusion through porins.

  2010cited by this paper
• The bacterial cell envelope.

  2010cited by this paper
• Three Decades of β-Lactamase Inhibitors

  2010cited by this paper
• How β-Lactam Antibiotics Enter Bacteria: A Dialogue with the Porins

  2009cited by this paper
• Simulating transport properties through bacterial channels.

  2009cited by this paper
• Outer membrane permeability and antibiotic resistance.

  2009cited by this paper
• Multidrug resistance in bacteria.

  2009cited by this paper
• Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.

  2009cited by this paper
• Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria.

  2009cited by this paper
• The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

  2009cited by this paper
• Efflux-Mediated Drug Resistance in Bacteria

  2009cited by this paper
• Activation of gene expression by small RNA.

  2009cited by this paper
• Inhibitors of multidrug resistant efflux systems in bacteria.

  2009cited by this paper
• Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence

  2009cited by this paper
• The clinical consequences of antimicrobial resistance.

  2009cited by this paper
• Bacterial Biocide Resistance

  2009cited by this paper
• Quinolone-resistant Salmonella Typhi in South Africa, 2003–2007

  2009cited by this paper
• Multidrug-Resistant Gram-Negative Infections

  2009cited by this paper

• Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance

  2019cites this paper
• Tea and coffee time with bacteria - Investigation of uptake of key coffee and tea phenolics by wild type E. coli.

  2018cites this paper
• Copper and Antibiotics: Discovery, Modes of Action, and Opportunities for Medicinal Applications.

  2017cites this paper
• Prediction of drug targets in human pathogens

  2017cites this paper
• Antimicrobial Drug Efflux Pumps in Enterobacter and Klebsiella

  2016cites this paper
• Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam

  2015cites this paper
• Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment

  2015cites this paper